Facts matter - and the facts are clear. The South

New Post Public Reply Private Reply Replies (0) Message Board
jmjjw
361
Facts matter - and the facts are clear. The South Orient/Texas-Pacifico rehabilitation project is in fact not fully funded. It is a matter of public record that certain portions of the project are funded through Federal FAST grants, administered by TXDOT, while significant portions - roughly 162 miles of required repair lack full funding. However, that is largely irrelevant, as MMEX via its proposed Phase I project would be unable to produce any products usable in Mexico.

If it were real, and ever built, the Phase I rudimentary topping unit, as (incompletely) permitted can produce three intermediate output streams:

- ATB, or Atmospheric Tank Bottoms (aka. “resid”).
- AGO, or Atmospheric Gas-Oil, a medium distillate, sometimes known as “straight run diesel”
- LGO, or Light Gas-Oil, a lighter fraction that contains what’s colloquially known as “naphtha,” along with kerosene, ethane, propane, and butane

None of those intermediate streams have any direct market use - all must be further refined to be consumed as fuel products, or used as feedstock. That processing is done in a real, complex refinery, not an imaginary “refinery” as proposed by MMEX.

ATB requires vacuum processing, and further complex processing, i.e. some form of cracking.

AGO requires hydro forming, stabilization, and stripping.

LGO requires stripping, depropanizing, demethanizing, deethanizing, an reforming.

All three streams require desulfurization. MMEX’s Phase I proposed system has none of these capabilities.

Further, MMEX and its illustrious partners “forgot” critical process capability, including desalting, pre-flash, and other critical loops including steam, critical pump-around, and redundant/bypass heat exchange. The immediate impact of these “forgotten” critical process elements was a $20-million error in the cost forecast, escalating MMEX’s required budget from “less than $49-million” to more than $70-million.

In reality, MMEX tried, as part of its charade, to use the TCEQ Permit By Rule (PBR) administrative permit approach to deceive investors. MMEX would be unable to meet the PBR thresholds for a Type O AQP if the required critical process elements had been in place (or get added later). Thus, the current Type O AQP is worthless - there is no process for amending it. This in turn leads to the necessity for MMEX to pursue full New Source Review (NSR), which costs millions, and takes from 18 - 24 months, even for a competent company to execute.

MMEX is a multi-dimensional failure, even if one gives it the benefit of doubt - in reality, it doesn’t matter, as MMEX is only a mediocre share-selling scheme.

As if MMEX needs more nails in its coffin, the problems with its proposed primary market are manifold. Mexico’s refining infrastructure is aged, and failing. Mexico suffers rampant hydrocarbon theft. The institutions responsible for all this are bankrupt, and corrupt. There is no market for ATB, AGO, or LGO in Mexico, even if MMEX had a way to transport it there. Here is one of dozens of sources for that information:

https://wolfstreet.com/2019/01/01/mexico-new-...8YkGl4gu-s

MMEX Resources Corporation (MMEX) Stock Research Links

MMEX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigating Potential Breach of Duty by RxSight, Inc. Executives

Updated Category News Views 206

Overview of the Investigation into RxSight, Inc. Robbins LLP, a respected law firm specializing in shareholder rights, has initiated an investigation into potential breaches of fiduciary duties by the officers and directors of RxSight, Inc. This medical technology company, noted for its innovative light adjustable intraocular lenses used in cataract surgeries, is now...

Continue Reading
Man Group PLC Announces Stake in Deliveroo plc Holdings

Updated Category News Views 131

Man Group PLC's Public Disclosure on Deliveroo Holdings Recently, Man Group PLC has disclosed significant information regarding their holdings and interests in Deliveroo plc. This action reflects the increasing transparency required under financial regulations aimed at ensuring fair play in the market. Stakeholders and investors alike are keenly observing these...

Continue Reading
Synthetic Biology Market Growth Forecast: US$ 126.9 Billion by 2034

Updated Category News Views 76

Overview of the Synthetic Biology Market The global synthetic biology market is set for remarkable growth, with forecasts showing an increase from US$ 14.5 billion in 2024 to US$ 126.9 billion by 2034. This impressive growth represents a compound annual growth rate (CAGR) of 24.2% over the next decade, underscoring the growing significance of this field across various...

Continue Reading
Quantum Computing Investors: Join the Class Action Opportunity

Updated Category News Views 105

Significant Opportunity for Quantum Computing Investors Investors of Quantum Computing Inc. (NASDAQ: QUBT) should take note of an important opportunity to participate in a class action lawsuit aimed at addressing substantial losses. This lawsuit has been initiated by Bronstein, Gewirtz & Grossman LLC, a reputable law firm known for its expertise in investor protection....

Continue Reading
Important Fiserv Class Action Lawsuit Details You Should Know

Updated Category News Views 131

Understanding the Fiserv Class Action Lawsuit Investors in Fiserv, Inc. have significant details to grasp concerning an ongoing class action lawsuit. This legal action runs the course of securities fraud allegations that have raised concerns among stakeholders. The importance of timely action cannot be overstated as investors look to protect their interests. Allegations...

Continue Reading